Akesiss is a rising star in the Pharmaceutical Industry, started the full-fledged Indian operations with the support of the U.S based NRI group. The Akesiss group has shaped its business in various independent healthcare verticals with the aim to deliver sustainable long-term value for patients, healthcare professionals, associates, partners, and stakeholders across the globe. Business:
Sales and
Marketing Divisions: Zalvo – Gynecology, Zalvo Life - Infertility, Glyvo – Diabetology, Glyvo Life - Cardio & Metabolic, Lazo – Orthopedic, and CCD – Critical Care
Manufacturing:
Megasys Biotek (A Subsidiary of Akesiss Pharma) – Formulation development, Pharmaceutical manufacturing, Formulation export,
The Akesiss Group’s fully integrated business model spans across the entire product value chain, right from formulation R&D to manufacturing and marketing. The Group is involved in developing a growing portfolio of best-in-class pharmaceutical formulations in the health care arena. The journey of Akesiss started as a small company that has now grown into a dynamic group catering to the requirements of the global healthcare industry at an affordable price. Currently, Akesiss Group occupies a prominent position in the manufacturing, marketing, and export of pharmaceutical formulations. Akesiss:
Akesiss is the marketing arm of the group involved in sales and marketing in India. Akesiss, “on a health mission with a global vision” is an established player in the Indian Pharmaceutical Industry. Today, Akesiss is catering to 15 therapeutic segments with its vast domestic reach across India; it has the right molecular selection which is widely accepted by the medical fraternity. Akesiss ensures innovations in various drug delivery systems as it implements stringent protocols to ensure maximum drug efficacy and compliance. Currently, Akesiss operates with a vast pool of well-trained and dedicated professionals in the domestic market through six marketing divisions – Zalvo, Zalvo Life, Glyvo, Glyvo Life, Lazo, & CCD. Megasys:
Megasys Biotek, the production house of the group has been built up with a reputation of excellence on the foundation of consistency of high quality, product portfolio, timely delivery, in compliance with international standards. Megasys has earned accolades from its customers in both the domestic and international markets. Commitment towards quality and customer satisfaction helped Megasys to maintain dominance in the global healthcare market. Global Accreditation: Akesiss is an ISO 9001:2015 certified company by the prestigious Certification body, “Bureau Verities of France” in accreditation with “UKAS” of the United Kingdom. Akesiss is among very few pharmaceutical companies in India to achieve this and that too within the first year of operation. Market Presence: It is a great achievement for the company that almost all brands of Akesiss are featuring in IQVIA and AICOD, the market intelligence companies that provides information for services and technology for the healthcare industry. As per recent their data, Akesiss has been ranked as one of the fastest-growing pharmaceutical company in India. To its credit, Akesiss has products that rank within the top 10 brands in India. Akesiss is continuously focused on improving the business by maintaining transparency in its operations and being open to the views and suggestions of the people involved in the Health Care Industry.
